Stockscreener 앱 받기
2.755
2.99%
0.075
전일 마감가:
$2.68
열려 있는:
$2.76
하루 거래량:
696.45K
Relative Volume:
0.56
시가총액:
$257.02M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-1.887
EPS:
-1.46
순현금흐름:
$-104.90M
1주 성능:
+23.77%
1개월 성능:
+50.00%
6개월 성능:
+208.21%
1년 성능:
+49.19%
1일 변동 폭
$2.70
$2.87
1주일 범위
$2.18
$2.87
52주 변동 폭
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
2.76 | 249.57M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
414.80 | 107.98B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.75 | 59.07B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.69 | 59.76B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
804.88 | 49.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
337.10 | 38.56B | 4.56B | -176.77M | 225.30M | -1.7177 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
How high can Caribou Biosciences Inc. stock go2025 Dividend Review & Community Shared Stock Ideas - newser.com
Using AI based signals to follow Caribou Biosciences Inc.Earnings Overview Summary & Weekly High Return Opportunities - newser.com
Evaluating Caribou Biosciences Inc. with trendline analysisTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Caribou Biosciences, Inc. $CRBU Shares Sold by Public Employees Retirement System of Ohio - Defense World
Real time social sentiment graph for Caribou Biosciences Inc.Market Growth Summary & Daily Risk Controlled Trade Plans - newser.com
Does Caribou Biosciences Inc. fit your quant trading model2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How to use a screener to detect Caribou Biosciences Inc. breakoutsRate Hike & Community Verified Trade Signals - newser.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Short interest data insights for Caribou Biosciences Inc.July 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Combining machine learning predictions for Caribou Biosciences Inc.Trade Signal Summary & Low Risk Entry Point Guides - newser.com
How Caribou Biosciences Inc. stock compares to market leaders2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Reversal indicators forming on Caribou Biosciences Inc. stockPortfolio Return Report & Step-by-Step Trade Execution Guides - newser.com
Published on: 2025-10-03 00:57:18 - newser.com
Published on: 2025-10-02 23:00:53 - newser.com
How to monitor Caribou Biosciences Inc. with trend dashboardsJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire
CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight - GlobeNewswire Inc.
BofA Securities Maintains Caribou Biosciences(CRBU.US) With Buy Rating - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
HC Wainwright Issues Negative Estimate for CRBU Earnings - Defense World
HC Wainwright Expects Lower Earnings for Caribou Biosciences - MarketBeat
Goldman Sachs Group Inc. Has $751,000 Stock Position in Caribou Biosciences, Inc. $CRBU - Defense World
What is HC Wainwright’s Estimate for CRBU FY2026 Earnings? - Defense World
What is HC Wainwright's Estimate for CRBU FY2026 Earnings? - MarketBeat
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
1.11%
자본화:
|
볼륨(24시간):